<i>Aspergillus</i> galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients

Swoboda-Kopeć E, Gołaś M, Piskorska K, et al. Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients. Central European Journal of Immunology. 2015;40(4):454-460. doi:10.5114/ceji.2015.56968.

APA

Swoboda-Kopeć, E., Gołaś, M., Piskorska, K., Dąbkowska, M., Niecwietajewa, I.,  & Pączek, L. et al. (2015). Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients. Central European Journal of Immunology, 40(4), 454-460. https://doi.org/10.5114/ceji.2015.56968

Chicago

Swoboda-Kopeć, Ewa, Marlena Gołaś, Katarzyna Piskorska, Maria Dąbkowska, Irena Niecwietajewa, Leszek Pączek,  and Magdalena Sikora. 2015. "Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients". Central European Journal of Immunology 40 (4): 454-460. doi:10.5114/ceji.2015.56968.

Harvard

Swoboda-Kopeć, E., Gołaś, M., Piskorska, K., Dąbkowska, M., Niecwietajewa, I., Pączek, L.,  and Sikora, M. (2015). Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients. Central European Journal of Immunology, 40(4), pp.454-460. https://doi.org/10.5114/ceji.2015.56968

MLA

Swoboda-Kopeć, Ewa et al. "Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients." Central European Journal of Immunology, vol. 40, no. 4, 2015, pp. 454-460. doi:10.5114/ceji.2015.56968.

Vancouver

Swoboda-Kopeć E, Gołaś M, Piskorska K, Dąbkowska M, Niecwietajewa I, Pączek L et al. Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients. Central European Journal of Immunology. 2015;40(4):454-460. doi:10.5114/ceji.2015.56968.

PlumX metrics:

Invasive aspergillosis (IA) is a severe infection with a 70% mortality rate. Aspergillus fumigatus is responsible for over 90% of those infections.

The diagnosis of invasive aspergillosis is based on clinical sample culture and detection of fungal hyphae in histopathological examination. Additional tests may include the detection of the galactomannan antigen and of fungal genetic material in serum and bronchoalveolar washings. The present study was to assess the use of these two rapid tests in the diagnosis of invasive aspergillosis: serological one – to detect the galactomannan antigen (ELISA assay), and real-time PCR, and to establish a possible correlation between these two methods.

keywords:

Aspergillus galactomannan detection in comparison to a real-time PCR assay in serum samples from a high-risk group of patients

Ewa Swoboda-Kopeć , Marlena Gołaś , Katarzyna Piskorska , Maria Dąbkowska , Irena Niecwietajewa , Leszek Pączek , Magdalena Sikora

Aspergillus, real-time PCR, galactomannan, aspergillosis, MycassayTM

Ewa Swoboda-Kopeć

,

Marlena Gołaś

,

Katarzyna Piskorska

,

Maria Dąbkowska

,

Irena Niecwietajewa

,

Leszek Pączek

,

Magdalena Sikora